United Imaging Healthcare Announces Q3 2024 Results With Revenue of January to September of 6.95 Billion CNY
United Imaging Healthcare Announces Q3 2024 Results With Revenue of January to September of 6.95 Billion CNY
Committed to advancing medical innovation through exceptional R&D capabilities and industry leadership, United Imaging Healthcare was recently honored on the SHANGHAI, Nov. 4, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE: 688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, announced its financial results for the third quarter of 2024. Reflecting its development strategy and strategic R&D investments, the company reported that revenue of January to September is 6.95 billion CNY, with net income attributable to shareholders reaching 0.67 billion CNY.
上海，2024年11月4日 / PRNewswire / - 聯影醫療（SSE：688271），全球醫療影像和放射治療設備製造領導者，宣佈2024年第三季度的財務業績。反映其發展策略和戰略研發投資，公司報告顯示，1月至9月份的營業收入爲69.5億人民幣，歸屬股東的淨利潤達到6.7億人民幣。
In 2024, United Imaging Healthcare has significantly increased its R&D efforts to pioneer high-end medical technologies and support the digital transformation of healthcare institutions. To date, over ten innovative United Imaging Healthcare products have received market approval,* including:
2024年，聯影醫療大幅增加了研發投入，致力於開拓高端醫療技術，支持醫療機構的數字化轉型。至今，聯影醫療已經獲得市場批准的十多個創新產品，包括：
- uLinac HalosTx, an integrated CT circular linear accelerator
- uMI Panvivo, a robust new PET/CT platform
- uMI Panorama GS, a next-generation, 148cm whole-body PET/CT system
- uOmnispace, a hospital-grade intelligent post-processing software suite
- uLinac HalosTx，一體化CT圓形直線加速器
- uMI Panvivo，強大的新PET/CT平台
- uMI Panorama GS，下一代148厘米全身PET/CT系統
- uOmnispace，醫院級智能後期處理軟件套件
These innovations, with the uMI Panorama molecular imaging solution as a key highlight, have gained international recognition. uMI Panorama has been installed at premier institutions in the United States. And, at the EANM 2024 the European Association of Nuclear Medicine (EANM) annual congress, United Imaging Healthcare launched its next-generation PET/CT system, the uMI Panvivo, which will be unveiled for U.S. audiences at the Radiologic Society of North America annual meeting in Chicago, as part of an innovation launch featuring multiple new products in several modalities.
這些創新，以uMI Panorama分子成像解決方案爲重點亮點，已獲得國際認可。uMI Panorama已安裝在美國的頂尖機構。而在2024年歐洲核醫學協會（EANM）年度大會上，聯影醫療推出了下一代PET/CT系統uMI Panvivo，並將在芝加哥舉行的北美放射學會年會上向美國觀衆展示，作爲一個創新發布的一部分，展示多個新產品的多種模式。
Committed to advancing medical innovation through exceptional R&D capabilities and industry leadership, United Imaging Healthcare was recently honored on the Fortune China Tech 50 for 2024. This prestigious recognition underscores United Imaging Healthcare's role in pioneering healthcare technology and elevating standards in medical imaging and patient care globally.
致力於通過卓越的研發能力和行業領導地位推進醫學創新，聯影醫療最近榮獲2024年《財富》中國科技50強榮譽。這一著名認可強調了聯影醫療在開創醫療技術和全球醫療影像及患者護理標準的角色。
*not all products noted are clinically or commercially available in the U.S.
在美國，並非所有產品均已經在臨床或商業上可用。
About United Imaging Healthcare
關於聯影醫療
At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment. Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All, we help drive industry progress and bold change. To learn more, visit
在聯影醫療，我們開發和生產先進的醫療產品、數字醫療解決方案，以及涵蓋影像診斷和治療整個過程的智能解決方案。我們成立於2011年，公司在中國、美國、波蘭、迪拜以及世界其他地區設有子公司和研發中心。憑藉前沿的數字產品組合和「平等醫療，服務全人類」的使命，我們推動行業進步和大膽變革。要了解更多，請訪問
譯文內容由第三人軟體翻譯。
